The Dermatology Digest

APRIL 3, 2024

Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. in September 2023.

Pharmaceutical 36

Pharmaceutical Sales Office Partnerships 36

The Dermatology Digest

FEBRUARY 8, 2024

This will be a game-changer if it pans out and may get us closer to disease cures via optimization of existing biological therapies,” he says. Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Hands Up for New CHE therapies Chronic hand eczema (CHE) will also get some love in 2024. And the Skin Disease of the Year Is….

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

AUGUST 8, 2024

Moreover, the researchers found that this heightened gene signature, as evidenced by the production of spleen tyrosine kinases, or the SYK pathway, did not interfere with the effectiveness of therapies in preventing recurrence of melanoma. The impact was connected only to side effects.

Treatments 74

Treatments Pharmaceutical Therapy Dermatology 74

The Dermatology Digest

MAY 2, 2024

Aslan and Zenyaku are teaming up to explore how eblasakimab’s mechanism of action differs from that of other biologic therapies for atopic dermatitis (AD).

Pharmaceutical 74

Pharmaceutical Dermatitis Office Clinic 74

Dermatology Times

DECEMBER 19, 2023

Dr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options.

Pharmaceutical 36

Pharmaceutical Dermatitis Therapy 36

The Dermatology Digest

MAY 15, 2024

Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. alone and no FDA approved therapies, common warts represent one of the largest unmet needs in all of dermatology. With a prevalence of approximately 22 million patients in the U.S.

Pharmaceutical 36

Pharmaceutical Clinic Sales Dermatology 36

Hollywood Institute

JANUARY 2, 2023

Not only is this condition curable, but you aren’t restricted to opioids or other pharmaceutical treatments. Curious if , massage therapy is the right solution for your chronic pain? What is Trigger Point Therapy? What are the Benefits of Trigger Point Therapy?

Therapy 52

Therapy Pharmaceutical Tools Irritation 52

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

Aesthetics Advisor

FEBRUARY 11, 2024

Most medical schools still only teach how to identify late-stage autoimmune disease, not how to identify autoimmunity in its early stages and nor how to affect its progression through dietary, nutritional, pharmaceutical, or lifestyle applications. Every supplement and every therapy is a shot in the dark.

Pharmaceutical 67

Pharmaceutical Diet Clinic Management 67

Aesthetics Advisor

AUGUST 15, 2023

Curcumin may help increase healthy p53 levels, and it has been shown to be a potentially effective cancer therapy supplement. s in the pharmaceutical and nutraceutical space, to develop processes that dramatically improve nutrient delivery into the bloodstream at previously unheard-of levels.

Therapy 69

Therapy Medical Safety Diet 69

The Dermatology Digest

MARCH 11, 2024

Watch Now Shared-Decision Making in AD Emma Guttman-Yassky, MD, PhD Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, discusses the factors that can affect choice of systemic therapy for atopic dermatitis (AD) patients. (..)

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

The Dermatology Digest

JULY 22, 2024

Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. Launches in further European countries are scheduled over the coming months, following national price approvals, via a fully European supply chain.

Partnerships 36

Partnerships Pharmaceutical Marketing Office 36

The Dermatology Digest

MAY 14, 2024

May is Ichthyosis Awareness Month, and TDD has curated its content on congenital ichthyosis (CI) to help raise awareness of the condition and shine a light on promising new therapies in the pipeline. Each year, more than 16,000 babies are born with some form of ichthyosis.

Pharmaceutical 36

Pharmaceutical Skin Types Dermatology Therapy 36

Aesthetics Advisor

FEBRUARY 22, 2025

Currently, there is no established pharmaceutical treatment for NAFLD, and dietary modifications are considered a primary approach to managing the disease. NAFLD encompasses a spectrum of conditions, ranging from simple steatosis (abnormal fat retention within a cell or organ) to non-alcoholic steatohepatitis.

Extractions 36

Extractions Medical Pharmaceutical Irritation 36

The Beauty Brains

APRIL 1, 2019

So, pharmaceutical companies are spending money researching this. J&J might discover something as they are a pharmaceutical company, but most beauty companies are not set up to develop these types of products. I’ll say up front, there is little evidence that cupping therapy has any real benefits. I feel your pain.

Pharmaceutical 52

Pharmaceutical Ingredients Facials Social Media 52

The Dermatology Digest

OCTOBER 26, 2024

Level Up is a phase 3b/4 global, randomized, open-label, efficacy assessor-blinded, head-to-head, multi-center study evaluating upadacitinib vs. dupilumab in adolescents and adults with moderate-to-severe AD who had an inadequate response to systemic therapy or when the use of those therapies was inadvisable.

Dermatitis 36

Dermatitis Treatments Pharmaceutical Eczema 36

The Dermatology Digest

OCTOBER 11, 2021

Hopefully in the future, we will be personalizing therapy selection based on clinical phenotypes or biomarkers. A small open-label study reported the benefit of ustekinumab (Stelara, Janssen Pharmaceuticals; Beerse, Belgium) in 82% of patients.

Pharmaceutical 36

Pharmaceutical Clinic Treatments Consultations 36

The Dermatology Digest

DECEMBER 15, 2023

AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. New biologics offer both more options for biologic-naive patients, but of course, also new alternatives for those who have had issues of one sort or another with existing therapies,” he says.

Dermatology 36

Dermatology Pharmaceutical Clinic Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. New biologics offer both more options for biologic-naive patients, but of course, also new alternatives for those who have had issues of one sort or another with existing therapies,” he says.

Dermatology 36

Dermatology Pharmaceutical Clinic Therapy 36

The Dermatology Digest

MARCH 10, 2024

Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA, reviews currently available and emerging treatments for chronic spontaneous urticaria (CSU), including dupilumab (Dupixent, Sanofi, and Regeneron Pharmaceuticals), remibrutinib, Novartis’ investigational oral Bruton’s tyrosine kinase (BTK) inhibitor, other BTK inhibitors, interleukin (..)

Treatments 36

Treatments Pharmaceutical Dermatitis Eczema 36

The Dermatology Digest

FEBRUARY 13, 2024

By disrupting the balance of two critical cellular pathways – the Ras pathway (affected by MEK inhibitors like Selumetinib) and the cAMP pathway (targeted by cAMP elevators like Ogerin) – this combination therapy emerges as a promising strategy.

Treatments 36

Treatments Pharmaceutical Surgery Scarring 36

Aesthetics Advisor

FEBRUARY 28, 2024

2 However, as "modern" medicine and the pharmaceutical industry ramped up the health care machine, vitamin C quickly fell out of favor as it is inexpensive, easy to administer and has very few side effects. They have asked us to state that this trial is negative and that we do not recommend it as a therapy.

Vitamin C 36

Vitamin C Pharmaceutical Hospital Therapy 36

Aesthetics Advisor

AUGUST 14, 2023

“If I see this presentation in someone on a statin medication, I will almost always assume the statin is at least a contributing factor and discuss with the patient its removal and replacement with another therapy.” Optimized niacin therapy costs patients $15 to 30 per month and is worth trying before statins, Dr. Smith added.

Document 36

Document Pharmaceutical Therapy Medical 36

The Dermatology Digest

AUGUST 14, 2024

Verrica Pharmaceuticals Inc.’s s VP-315 is showing promise in the treatment of basal cell carcinoma, according to Part 2 of its Phase 2 clinical trial. VP-315 is a potential first-in-class oncolytic peptide immunotherapy designed to be administered directly into a tumor to induce immunogenic cell death.

Pharmaceutical 36

Pharmaceutical Safety Clinic Scarring 36

Aesthetics Advisor

AUGUST 22, 2023

In this era of readily available pharmaceutical products for every imaginable ailment, it can be easy to default to the drug store when we need relief. Medieval Persian pharmaceutical manuscripts refer to 1200 types of oxymel. It has not always been that way. Reposted from: [link]

Extractions 36

Extractions Pharmaceutical Diet Ingredients 36

New Age Spa Institute

SEPTEMBER 28, 2023

Our esthetics, massage therapy, and make up students study the history of beauty culture through the ages. New Age Spa Institute recommends: Phytoboost – from the Coterie Fresh ‘N Clear line of pharmaceutical grade skincare prdocuts. Contains 90% Green Tea Polyphenols – the highest percentage synthesized effectively.

Skincare 52

Skincare Esthetics Esthetician Extractions 52

Aesthetics Advisor

FEBRUARY 7, 2024

Carnosine Protects Against LA-Induced Oxidative Stress One benefit not expounded upon in the Pharmaceuticals paper is carnosine’s ability to reduce LA-induced oxidative stress. Experiments on aged rats showed that therapy with 250 mg/kg/carnosine per day significantly decreased oxidative stress and increased activity of antioxidative enzymes.

Pharmaceutical 36

Pharmaceutical Diet Retinol Injections 36

Aesthetics Advisor

SEPTEMBER 3, 2023

Even though TNBC has a high frequency of overexpressing EGFR, previous anti-EGFR therapies have been largely unsuccessful. The in vitro success of melittin as an anti-EGFR therapy shows promise for translation to future TNBC clinical trials. over chemotherapy alone.

Treatments 36

Treatments Pores Therapy Injections 36

The Dermatology Digest

MARCH 11, 2024

Watch Now Shared-Decision Making in AD Emma Guttman-Yassky, MD, PhD Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, discusses the factors that can affect choice of systemic therapy for atopic dermatitis (AD) patients. (..)

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Watch Now Shared-Decision Making in AD Emma Guttman-Yassky, MD, PhD Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, discusses the factors that can affect choice of systemic therapy for atopic dermatitis (AD) patients. (..)

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Watch Now Shared-Decision Making in AD Emma Guttman-Yassky, MD, PhD Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, discusses the factors that can affect choice of systemic therapy for atopic dermatitis (AD) patients. (..)

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 10, 2024

Watch Now Shared-Decision Making in AD Emma Guttman-Yassky, MD, PhD Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, discusses the factors that can affect choice of systemic therapy for atopic dermatitis (AD) patients. (..)

Treatments 36

Treatments Dermatitis Eczema Dermatology 36

New Age Spa Institute

JUNE 22, 2023

However, the connection between beauty culture and pharmaceutical interventions is one that demands critical examination. From flawless skin to a slim figure, people find themselves going to extreme lengths to achieve the desired aesthetic of the moment.

Esthetics 40

Esthetics Social Media Continuing Education Continuous Education 40

Aesthetics Advisor

FEBRUARY 11, 2024

Social media posts featuring strange decoctions and peculiar natural treatments flood the internet daily, offering hope to those seeking alternatives to established pharmaceutical approaches. However, that should not be a hindrance, as there is no such thing as overdosing on turmeric.

Ingredients 36

Ingredients Pharmaceutical Extractions Social Media 36

West Lake Dermatology

OCTOBER 15, 2024

GLP-1’s unique ability to affect both glucose metabolism and appetite makes it a critical hormone in weight management and a target for pharmaceutical treatments aimed at curbing hunger and improving metabolic health. At the same time, GLP-1 signals to the brain that the stomach is full, helping to suppress appetite.

Medical 36

Medical Management Sustainability Pharmaceutical 36

Aesthetics Advisor

JANUARY 27, 2024

Use of medication with significant anticholinergic activity should likely be discouraged in older adults if alternative therapies are available,” Ms. We just have a few that are deeply affected by psych drugs, and [those are the ones we] could study because the drug companies in the pharmaceutical industry pay for that.”

Medical 36

Medical Pharmaceutical Marketing Therapy 36

Aesthetics Advisor

FEBRUARY 9, 2024

A cosmeceutical is essentially a skincare product that contains a biologically active compound that is thought to have pharmaceutical effects on the skin. Both pharmaceutical and cosmeceutical grade skin care products actively effect skin at a cellular level, whereas cosmetic products have a shorter-term effect.

Ingredients 36

Ingredients Vitamin C Retinol Collagen 36